QHSLab, Inc. Stock

USAQ

US90350R1077

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 21:53:46 27/07/2026 HKT			5-day change	1st Jan Change
0.3480 ^USD	+16.00%		+46.84%	-42.56%

05-14	QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-21	QHSLab Launches Q-Connect Glp-1 Support Assessment	CI

QHSLab, Inc. is a medical device technology and software as a service (SaaS) company focused on primary care physicians (PCPs) and other healthcare providers to offer tools to evaluate and treat chronic diseases as well as provide preventive care through reimbursable procedures. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. It also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The Company sells allergy diagnostic-related products and immunotherapy treatments to physicians.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
27/07/26	US$0.3480	+16.00%	1,059
24/07/26	US$0.3000	0.00%	1,010
23/07/26	US$0.3000	+6.38%	2,000
22/07/26	US$0.2820	+18.99%	2,800
21/07/26	US$0.2370	-10.57%	6,501

Delayed Quote OTC Markets

More quotes

Income Statement and Estimates

More financial data

Market Cap	5.23M 4.56M 4.26M 3.91M 7.34M 500M 7.52M 50.45M 19.71M 248M 19.64M 19.21M 854M	P/E 2024	-8.27x	P/E 2025	30.3x
Enterprise Value	4.89M 4.26M 3.98M 3.66M 6.86M 467M 7.02M 47.14M 18.42M 232M 18.35M 17.95M 798M	EV / Sales 2024	1.97x	EV / Sales 2025	2.41x
Free-Float	51.27%	Yield 2024 *	-	Yield 2025	-

05-14	QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-21	QHSLab Launches Q-Connect Glp-1 Support Assessment	CI
03-30	QHSLab, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-30	QHSLab, Inc. Auditor Raises 'Going Concern' Doubt	CI
12-26	QHSLab, Inc. announced that it has received $0.499999 million in funding	CI
12-03	QHSLab Inc. Announces Launch of Q-Cog to Support Early Detection of Mild Cognitive Impairment and Dementia	CI
11-18	QHSLab (OTCQB:USAQ) completes repurchase of legacy debt, enhancing capital structure, strengthening balance sheet and reducing future dilution	RE
11-13	QHSLab, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
03/09/25	QHSLab, Inc. Rolls Out Breakthrough Pediatric Screening Tool Linking Allergies and Mental Health	CI
14/08/25	QHSLab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
08/07/25	QHSLab Inc. Opens Doors in Miami to Expand Access to Mental Health Services	CI
03/06/25	QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency	CI
15/05/25	Qhslab Q1 Gross Margin 66.6%	RE

04-21	QHSLab (OTCQB:USAQ) Reports 127% Year-Over-Year ISP Growth and Launches Q-Connect GLP-1 Support Assessment	AQ
03-31	QHSLab (OTCQB:USAQ) Reports Strong Fiscal 2025 Results with Revenue Growth, Expanding Margins, and Significant Balance Sheet Improvement	AQ
02-19	Burnham USA Equities Retains Hanley Investment Group to Market for Sale LOCAL, a Newly Renovated and Rebranded Lifestyle Retail Center in Mission Viejo	AQ
01-26	QHSLab (OTCQB:USAQ) Reports Preliminary Unaudited 2025 Financial Results With Strong Revenue Growth, Expanding Margins, and Significant Debt Reduction	AQ
01-16	QHSLab (OTCQB:USAQ) Initiates Board Expansion Process to Strengthen Governance and Support Next Phase of Growth	AQ

1 day	+16.00%
1 week	+46.84%
Current month	+31.32%
1 month	+31.32%
3 months	-36.48%
6 months	-54.21%
Current year	-42.56%

1 week	0.3	0.35
1 month	0.24	0.42
Current year	0.24	1.14
1 year	0.08	1.14
3 years	0.02	1.14
5 years	0.02	1.14
10 years	0	1.14

QHSLab, Inc. Stock

Stocks

USAQ

US90350R1077

Advanced Medical Equipment & Technology

Valuation: QHSLab, Inc.

Chart: QHSLab, Inc.

Latest news : QHSLab, Inc.

Press Releases: QHSLab, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: QHSLab, Inc.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Manager	Title	Age	Since
Troy Grogan CEO	Chief Executive Officer	49	28/06/2016
Jeremy Jacob CTO	Chief Tech/Sci/R&D Officer	-	-
Marcos Sanchez-Gonzalez CTO	Chief Tech/Sci/R&D Officer	-	02/05/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
31/12/25	Troy Grogan	Others	Chief Executive Officer	2,644,424	100.0000%
31/12/25	Troy Grogan	Others	Chief Executive Officer	1,080,092	100.0000%
31/12/25	Troy Grogan	Conversion	Chief Executive Officer	213,075	1.8887%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
QHSLAB, INC.	+16.00%	+46.84%	+86.60%	+364.00%	5.23M
THERMO FISHER SCIENTIFIC, INC.	+0.01%	+10.12%	+18.87%	+2.60%	214B
DANAHER CORPORATION	-1.29%	+9.76%	-3.18%	-24.45%	140B
INTUITIVE SURGICAL, INC.	-2.40%	+0.87%	-28.52%	+8.14%	128B
BOSTON SCIENTIFIC CORPORATION	-0.04%	+6.60%	-56.50%	-10.93%	68.46B
EDWARDS LIFESCIENCES CORPORATION	+2.49%	+1.43%	+9.26%	+2.41%	48.18B
SIEMENS HEALTHINEERS AG	+4.51%	+8.78%	-21.58%	-28.66%	45.56B
AGILENT TECHNOLOGIES, INC.	-0.17%	+5.60%	+17.37%	+11.31%	39.69B
WATERS CORPORATION	-1.15%	+3.25%	+25.51%	+32.79%	37.69B
RESMED, INC.	+2.55%	+9.44%	-21.65%	-3.98%	30.14B
Average	+2.55%	+7.20%	+2.62%	+35.32%	75.17B
Weighted average by Cap.	+0.83%	+5.29%	-4.60%	-2.92%

	2024	2025
Net sales	2.13M 1.86M 1.73M 1.59M 2.99M 204M 3.06M 20.56M 8.03M 101M 8M 7.83M 348M	2.69M 2.35M 2.19M 2.01M 3.78M 257M 3.87M 25.96M 10.14M 128M 10.11M 9.89M 440M
Net income	-259K -226K -211K -194K -364K -24.79M -372K -2.5M -977K -12.28M -973K -952K -42.34M	457K 399K 372K 342K 642K 43.75M 657K 4.41M 1.72M 21.67M 1.72M 1.68M 74.71M
Net Debt	1.58M 1.38M 1.28M 1.18M 2.22M 151M 2.27M 15.22M 5.95M 74.81M 5.93M 5.8M 258M	-343K -299K -279K -257K -482K -32.83M -493K -3.31M -1.29M -16.27M -1.29M -1.26M -56.07M